Soliris and Cytoxan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Soliris (eculizumab) and Cytoxan (cyclophosphamide). Common drug interactions include hypocalcaemia among females and bk virus infection among males.

The phase IV clinical study analyzes what interactions people have when they take Soliris and Cytoxan. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Soliris?

Soliris has active ingredients of eculizumab. It is often used in paroxysmal nocturnal hemoglobinuria (pnh). eHealthMe is studying from 58,821 Soliris users. Check the latest studies of Soliris.

What is Cytoxan?

Cytoxan has active ingredients of cyclophosphamide. It is often used in breast cancer. eHealthMe is studying from 19,693 Cytoxan users. Check the latest studies of Cytoxan.



On Jul, 04, 2026

21 people who take Soliris and Cytoxan together, and have interactions are studied.

Soliris and Cytoxan drug interactions.

What are the common drug interactions of Soliris and Cytoxan, by gender? *:

female:

  1. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  2. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  3. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  4. Hypoxia (low oxygen in tissues)
  5. Impaired healing
  6. Influenza like illness
  7. Intervertebral disc degeneration (spinal disc degeneration)
  8. Intervertebral disc protrusion (spinal disc protrusion)
  9. Leukocytosis (increased white blood cells)
  10. Malaise (a feeling of general discomfort or uneasiness)

male:

  1. Bk virus infection
  2. Leukopenia (less number of white blood cells in blood)
  3. Chemotherapy
  4. Coagulopathy (blood's ability to clot is impaired)
  5. Crepitations (noises are produced by the rubbing of parts one against the other)
  6. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  7. Depressed level of consciousness
  8. Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
  9. Fluid overload (too much fluid in the blood)
  10. Fungaemia (fungi circulate in the blood)

What are the common drug interactions of Soliris and Cytoxan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Death
  2. Iga nephropathy (kidney disease- condition prevents the kidneys from filtering waste)
  3. Pyrexia (fever)
  4. Renal osteodystrophy (a bone disease occurs when the kidneys fail to maintain the proper levels of calcium and phosphorus in the blood)
  5. Seizure (abnormal excessive or synchronous neuronal activity in the brain)

10-19:

n/a

20-29:

  1. Haematocrit decreased
  2. Haemoglobin decreased
  3. Platelet count decreased

30-39:

n/a

40-49:

  1. Hyperlipidaemia (presence of excess lipids in the blood)
  2. Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)
  3. Hypersensitivity
  4. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  5. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  6. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  7. Hypoxia (low oxygen in tissues)
  8. Impaired healing
  9. Influenza like illness
  10. Infusion related reaction

50-59:

  1. Depression
  2. Fatigue (feeling of tiredness)
  3. Gallbladder polyp (growths or lesions resembling growths (polypoid lesions) in the wall of the gallbladder)
  4. Injection site erythema (redness at injection site)
  5. Injection site pruritus (severe itching at injection site)
  6. Injection site reaction
  7. Injection site swelling
  8. Injection site warmth
  9. Weight increased

60+:

  1. Aphasia (damage to the parts of the brain that control language)
  2. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Depressed level of consciousness
  5. Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
  6. Fatigue (feeling of tiredness)
  7. Fluid overload (too much fluid in the blood)
  8. Fungaemia (fungi circulate in the blood)
  9. Fungal infection
  10. Haemoglobin decreased

What are the existing conditions these people have? *

  1. Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 8 people, 38.10%
  2. Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 6 people, 28.57%
  3. Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 4 people, 19.05%
  4. High Blood Pressure: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Soliris and Cytoxan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Soliris and Cytoxan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Soliris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cytoxan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Soliris and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cytoxan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on eculizumab and cyclophosphamide (the active ingredients of Soliris and Cytoxan, respectively), and Soliris and Cytoxan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: